Skip to main content

Blackstone Announces $14.6B Recapitalization of BioMed Realty

Press releases | October 16, 2020

Fried Frank acted as counsel to Morgan Stanley as financial advisor to Blackstone Real Estate Partners VIII L.P. (BREP VIII) in its US$14.6 billion sale of BioMed Realty (BioMed) to a group led by existing BioMed investors. BioMed is the largest private owner of life science office buildings in the United States. The investment will generate US$6.5 billion of cumulative profits for BREP VIII and BioMed co-investors. Blackstone is conducting a “go-shop" process on behalf of BioMed's current investors, which will be led by Morgan Stanley. The recapitalization is expected to close after the conclusion of the “go-shop" process.

The Fried Frank team was led by corporate partner Philip Richter and included corporate partner Stuart A. Barr, corporate special counsel Roy Tannenbaum, and corporate associate Justin A. Schenck.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.